Maternal embryonic leucine zipper kinase (MELK): A novel regulator in cell cycle control, embryonic development, and cancer

International Journal of Molecular Sciences

Volumn 14, Issue 11, 2013, Pages 21551-21560

  Jiang, Pengfei ^a   Zhang, Deli ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

Cell cycle; Embryonic development; Maternal embryonic leucine zipper kinase; Protein interaction; Therapeutic target; Tumorigenic process

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; BINDING PROTEIN; MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; PROGRAMMED DEATH 1 RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; UNCLASSIFIED DRUG;

APOPTOSIS; ASTROCYTOMA; BREAST CANCER; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HEMATOPOIESIS; HUMAN; MELANOMA; NEOPLASM; NEUROBLAST; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA PROCESSING; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; XENOPUS;

APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; EMBRYONIC DEVELOPMENT; HUMANS; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; SPLICEOSOMES;

EID: 84887197887     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141121551     Document Type: Review

References (55)

1. Gil, M.; Yang, Y.; Lee, Y.; Choi, I.; Ha, H. Cloning and expression of a cdna encoding a novel protein serine/threonine kinase predominantly expressed in hematopoietic cells. Gene 1997, 195, 295-301.
2. Blot, J.; Chartrain, I.; Roghi, C.; Philippe, M.; Tassan, J. P. Cell cycle regulation of peg3, a new xenopus protein kinase of the KIN1/PAR-1/MARK family. Dev. Biol. 2002, 241, 327-338.
3. Heyer, B. S.; Warsowe, J.; Solter, D.; Knowles, B. B.; Ackerman, S. L. New member of the SNF1/AMPK kinase family, melk, is expressed in the mouse egg and preimplantation embryo. Mol. Reprod. Dev. 1997, 47, 148-156.
4. Davezac, N.; Baldin, V.; Blot, J.; Ducommun, B.; Tassan, J. P. Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: A potential role for pEg3 in cell cycle regulation. Oncogene 2002, 21, 7630-7641.
5. Tassan, J. P.; le Goff, X. An overview of the KIN1/PAR-1/MARK kinase family. Biol. Cell 2004, 96, 193-199.
6. Kato, K.; Ogura, T.; Kishimoto, A.; Minegishi, Y.; Nakajima, N.; Miyazaki, M.; Esumi, H. Critical roles of amp-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 2002, 21, 6082-6090.
7. Inoki, K.; Zhu, T.; Guan, K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115, 577-590.
8. Suzuki, A.; Kusakai, G.; Kishimoto, A.; Lu, J.; Ogura, T.; Esumi, H. ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or uv irradiation. Oncogene 2003, 22, 6177-6182.
9. Suzuki, A.; Kusakai, G.; Kishimoto, A.; Lu, J.; Ogura, T.; Lavin, M. F.; Esumi, H. Identification of a novel protein kinase mediating Akt survival signaling to the atm protein. J. Biol. Chem. 2003, 278, 48-53.
10. Nakano, I.; Paucar, A. A.; Bajpai, R.; Dougherty, J. D.; Zewail, A.; Kelly, T. K.; Kim, K. J.; Ou, J.; Groszer, M.; Imura, T.; et al. Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation. J. Cell Biol. 2005, 170, 413-427.
11. Lin, M. L.; Park, J. H.; Nishidate, T.; Nakamura, Y.; Katagiri, T. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-g, a pro-apoptotic member of the Bcl-2 family. Breast Cancer Res. 2007, 9, R17.
12. Jung, H.; Seong, H. A.; Ha, H. Murine protein serine/threonine kinase 38 activates apoptosis signal-regulating kinase 1 via Thr 838 phosphorylation. J. Biol. Chem. 2008, 283, 34541-34553.
13. Vulsteke, V.; Beullens, M.; Boudrez, A.; Keppens, S.; van Eynde, A.; Rider, M. H.; Stalmans, W.; Bollen, M. Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1. J. Biol. Chem. 2004, 279, 8642-8647.
14. Kidder, G. M. The genetic program for preimplantation development. Dev. Genet. 1992, 13, 319-325.
15. Heyer, B. S.; Kochanowski, H.; Solter, D. Expression of MELK, a new protein kinase, during early mouse development. Dev. Dyn. 1999, 215, 344-351.
16. Le Page, Y.; Chartrain, I.; Badouel, C.; Tassan, J. P. A functional analysis of MELK in cell division reveals a transition in the mode of cytokinesis during xenopus development. J. Cell Sci. 2011, 124, 958-968.
17. Chung, S.; Suzuki, H.; Miyamoto, T.; Takamatsu, N.; Tatsuguchi, A.; Ueda, K.; Kijima, K.; Nakamura, Y.; Matsuo, Y. Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. Oncotarget 2012, 3, 1629-1640.
18. Niesler, C. U.; Myburgh, K. H.; Moore, F. The changing AMPK expression profile in differentiating mouse skeletal muscle myoblast cells helps confer increasing resistance to apoptosis. Exp. Physiol. 2007, 92, 207-217.
19. Pickard, M. R.; Green, A. R.; Ellis, I. O.; Caldas, C.; Hedge, V. L.; Mourtada-Maarabouni, M.; Williams, G. T. Dysregulated expression of fau and MELK is associated with poor prognosis in breast cancer. Breast Cancer Res. 2009, 11, R60.
20. Saito, R.; Nakauchi, H.; Watanabe, S. Serine/threonine kinase, MELK, regulates proliferation and glial differentiation of retinal progenitor cells. Cancer Sci. 2012, 103, 42-49.
21. Cordes, S.; Frank, C. A.; Garriga, G. The C. elegans MELK ortholog pig-1 regulates cell size asymmetry and daughter cell fate in asymmetric neuroblast divisions. Development 2006, 133, 2747-2756.
22. Nishitoh, H.; Saitoh, M.; Mochida, Y.; Takeda, K.; Nakano, H.; Rothe, M.; Miyazono, K.; Ichijo, H. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 1998, 2, 389-395.
23. Chang, H. Y.; Nishitoh, H.; Yang, X.; Ichijo, H.; Baltimore, D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein daxx. Science 1998, 281, 1860-1863.
24. Matsuura, H.; Nishitoh, H.; Takeda, K.; Matsuzawa, A.; Amagasa, T.; Ito, M.; Yoshioka, K.; Ichijo, H. Phosphorylation-dependent scaffolding role of JSAP1/JIP3 in the ASK1-JNK signaling pathway. A new mode of regulation of the map kinase cascade. J. Biol. Chem. 2002, 277, 40703-40709.
25. Saitoh, M.; Nishitoh, H.; Fujii, M.; Takeda, K.; Tobiume, K.; Sawada, Y.; Kawabata, M.; Miyazono, K.; Ichijo, H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998, 17, 2596-2606.
26. Liu, H.; Nishitoh, H.; Ichijo, H.; Kyriakis, J. M. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the Ask1 inhibitor thioredoxin. Mol. Cell Biol. 2000, 20, 2198-2208.
27. Song, J. J.; Rhee, J. G.; Suntharalingam, M.; Walsh, S. A.; Spitz, D. R.; Lee, Y. J. Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2. J. Biol. Chem. 2002, 277, 46566-46575.
28. Park, H. S.; Cho, S. G.; Kim, C. K.; Hwang, H. S.; Noh, K. T.; Kim, M. S.; Huh, S. H.; Kim, M. J.; Ryoo, K.; Kim, E. K.; et al. Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol. Cell Biol. 2002, 22, 7721-7730.
29. Kim, A. H.; Khursigara, G.; Sun, X.; Franke, T. F.; Chao, M. V. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol. Cell Biol. 2001, 21, 893-901.
30. Morita, K.; Saitoh, M.; Tobiume, K.; Matsuura, H.; Enomoto, S.; Nishitoh, H.; Ichijo, H. Negative feedback regulation of ASK1 by protein phosphatase 5 (pp5) in response to oxidative stress. EMBO J. 2001, 20, 6028-6036.
31. Zhang, L.; Chen, J.; Fu, H. Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc. Natl. Acad. Sci. USA 1999, 96, 8511-8515.
32. Seong, H. A.; Ha, H. Murine protein serine-threonine kinase 38 activates p53 function through ser15 phosphorylation. J. Biol. Chem. 2012, 287, 20797-20810.
33. Ohsugi, M.; Hwang, S. Y.; Butz, S.; Knowles, B. B.; Solter, D.; Kemler, R. Expression and cell membrane localization of catenins during mouse preimplantation development. Dev. Dyn. 1996, 206, 391-402.
34. Geschwind, D. H.; Ou, J.; Easterday, M. C.; Dougherty, J. D.; Jackson, R. L.; Chen, Z.; Antoine, H.; Terskikh, A.; Weissman, I. L.; Nelson, S. F.; et al. A genetic analysis of neural progenitor differentiation. Neuron 2001, 29, 325-339.
35. Terskikh, A. V.; Easterday, M. C.; Li, L.; Hood, L.; Kornblum, H. I.; Geschwind, D. H.; Weissman, I. L. From hematopoiesis to neuropoiesis: Evidence of overlapping genetic programs. Proc. Natl. Acad. Sci. USA 2001, 98, 7934-7939.
36. Saito, R.; Tabata, Y.; Muto, A.; Arai, K.; Watanabe, S. MELK-like kinase plays a role in hematopoiesis in the zebra fish. Mol. Cell Biol. 2005, 25, 6682-6693.
37. Liu, G.; Yuan, X.; Zeng, Z.; Tunici, P.; Ng, H.; Abdulkadir, I. R.; Lu, L.; Irvin, D.; Black, K. L.; Yu, J. S. Analysis of gene expression and chemoresistance of cd133+ cancer stem cells in glioblastoma. Mol. Cancer 2006, 5, 67.
38. Ryu, B.; Kim, D. S.; Deluca, A. M.; Alani, R. M. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One 2007, 2, e594.
39. Marie, S. K.; Okamoto, O. K.; Uno, M.; Hasegawa, A. P.; Oba-Shinjo, S. M.; Cohen, T.; Camargo, A. A.; Kosoy, A.; Carlotti, C. G., Jr.; Toledo, S.; et al. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int. J. Cancer 2008, 122, 807-815.
40. Gray, D.; Jubb, A. M.; Hogue, D.; Dowd, P.; Kljavin, N.; Yi, S.; Bai, W.; Frantz, G.; Zhang, Z.; Koeppen, H.; et al. Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers. Cancer Res. 2005, 65, 9751-9761.
41. Hemmati, H. D.; Nakano, I.; Lazareff, J. A.; Masterman-Smith, M.; Geschwind, D. H.; Bronner-Fraser, M.; Kornblum, H. I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 2003, 100, 15178-15183.
42. Choi, S.; Ku, J. L. Resistance of colorectal cancer cells to radiation and 5-fu is associated with MELK expression. Biochem. Biophys. Res. Commun. 2011, 412, 207-213.
43. Rhodes, D. R.; Yu, J.; Shanker, K.; Deshpande, N.; Varambally, R.; Ghosh, D.; Barrette, T.; Pandey, A.; Chinnaiyan, A. M. Large-Scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. USA 2004, 101, 9309-9314.
44. Hebbard, L. W.; Maurer, J.; Miller, A.; Lesperance, J.; Hassell, J.; Oshima, R. G.; Terskikh, A. V. Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo. Cancer Res. 2010, 70, 8863-8873.
45. Ku, J. L.; Shin, Y. K.; Kim, D. W.; Kim, K. H.; Choi, J. S.; Hong, S. H.; Jeon, Y. K.; Kim, S. H.; Kim, H. S.; Park, J. H.; et al. Establishment and characterization of 13 human colorectal carcinoma cell lines: Mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers. Carcinogenesis 2010, 31, 1003-1009.
46. Guo, B.; Godzik, A.; Reed, J. C. Bcl-g, a novel pro-apoptotic member of the Bcl-2 family. J. Biol. Chem. 2001, 276, 2780-2785.
47. Nakano, I.; Masterman-Smith, M.; Saigusa, K.; Paucar, A. A.; Horvath, S.; Shoemaker, L.; Watanabe, M.; Negro, A.; Bajpai, R.; Howes, A.; et al. Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J. Neurosci. Res. 2008, 86, 48-60.
48. Nakano, I.; Joshi, K.; Visnyei, K.; Hu, B.; Watanabe, M.; Lam, D.; Wexler, E.; Saigusa, K.; Nakamura, Y.; Laks, D. R.; et al. Siomycin a targets brain tumor stem cells partially through a MELK-mediated pathway. Neuro Oncol. 2011, 13, 622-634.
49. Beullens, M.; Vancauwenbergh, S.; Morrice, N.; Derua, R.; Ceulemans, H.; Waelkens, E.; Bollen, M. Substrate specificity and activity regulation of protein kinase MELK. J. Biol. Chem. 2005, 280, 40003-40011.
50. Seong, H. A.; Jung, H.; Ha, H. Murine protein serine/threonine kinase 38 stimulates TGF-beta signaling in a kinase-dependent manner via direct phosphorylation of smad proteins. J. Biol. Chem. 2010, 285, 30959-30970.
51. Seong, H. A.; Gil, M.; Kim, K. T.; Kim, S. J.; Ha, H. Phosphorylation of a novel zinc-finger-like protein, ZPR9, by murine protein serine/threonine kinase 38 (MPK38). Biochem. J. 2002, 361, 597-604.
52. Seong, H. A.; Kim, K. T.; Ha, H. Enhancement of B-MYB transcriptional activity by ZPR9, a novel zinc finger protein. J. Biol. Chem. 2003, 278, 9655-9662.
53. Wang, C.; Liu, M.; Riojas, R. A.; Xin, X.; Gao, Z.; Zeng, R.; Wu, J.; Dong, L. Q.; Liu, F. Protein kinase c theta (PKCtheta)-dependent phosphorylation of PDK1 at Ser504 and Ser532 contributes to palmitate-induced insulin resistance. J. Biol. Chem. 2009, 284, 2038-2044.
54. Seong, H. A.; Jung, H.; Ichijo, H.; Ha, H. Reciprocal negative regulation of PDK1 and ASK1 signaling by direct interaction and phosphorylation. J. Biol. Chem. 2010, 285, 2397-2414.
55. Badouel, C.; Korner, R.; Frank-Vaillant, M.; Couturier, A.; Nigg, E. A.; Tassan, J. P. M-Phase MELK activity is regulated by MPF and MAPK. Cell Cycle 2006, 5, 883-889.